Results 101 to 110 of about 28,637 (186)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy. [PDF]

Blood Adv, 2023
Meloni A, Pistoia L, Ricchi P, Allò M, Rosso R, Cuccia L, Casini T, Cecinati V, Serra M, Rossi V, Righi R, Renne S, Vallone A, Positano V, Cademartiri F.   +14 more
europepmc   +1 more source

Iron shuttle chelation therapy enhances to reduce misplaced iron on secondary iron overloaded adult zebrafish [PDF]

, 2017
Thalassemia is the most common genetically inherited blood disorder in the world arises from defect in hemoglobin production, results in ineffective erythropoiesis and the rapid destruction of RBC in the periphery that leads to severe anemia.
Mustafa, Ibrahim, Nasrellah, Gheyath, Younes, Salma Nagy, Saleem, Rola, Khalaf, Israa Magdi Nassef   +4 more
core  

The trial to assess chelation therapy 2 (TACT2): Rationale and design. [PDF]

Am Heart J, 2022
Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Kim H, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Santella RM, Escolar E, Aude YW, Fonseca V, Elliott T, Lewis EF, Farkouh ME, Nathan DM, Mon AC, Gosnell L, Newman JD, Mark DB, TACT2 Investigators.   +21 more
europepmc   +1 more source

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. [PDF]

Cochrane Database Syst Rev, 2023
Geneen LJ, Dorée C, Estcourt LJ.
europepmc   +1 more source

Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review. [PDF]

Hemoglobin, 2022
Locke M, Reddy PS, Badawy SM.
europepmc   +1 more source

Evaluation of Cardiac Systolic and Diastolic Function by Echocardiographic Tei Index in Thalassemic Patients Referring to HazrateMasoumeh Hospital, Qom, Iran, 2012-2013

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2015
Background and Objectives: Early diagnosis of secondary cardiac involvement due to iron overload is very important in thalassemia patients. The aim of this study was to evaluate cardiac systolic and diastolic function by Tei Index in patients with β-
Mohammad Hossein Arjmandnia, Parvaneh Sadeghi Moghaddam, Seyed Kamal Eshagh Hosseini, Hamed Hassani, Mohammad Aghaali   +4 more
doaj  

Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results. [PDF]

Antioxidants (Basel), 2023
Vezzoli A, Mrakic-Sposta S, Dellanoce C, Montorsi M, Vietti D, Ferrero ME.   +5 more
europepmc   +1 more source

Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review. [PDF]

J Am Heart Assoc, 2022
Ravalli F, Vela Parada X, Ujueta F, Pinotti R, Anstrom KJ, Lamas GA, Navas-Acien A.   +6 more
europepmc   +1 more source

Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan. [PDF]

Sci Rep
Shah AWA, Shams S, Khan MJ, Ullah N, Ullah MJ, Inayat F.   +5 more
europepmc   +1 more source

Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy. [PDF]

Ther Adv Endocrinol Metab
Al-Sanabra OM, Abbas MA, Hazàa AA, Hazà WJ.   +3 more
europepmc   +1 more source